
The Christie's 'first of its kind' scanner that could transform cancer treatment
A pioneering new scanner at the Manchester hospital could change the way cancer is treated
Browse recent medication, recall, and health-related stories.
Page 23 of 51

A pioneering new scanner at the Manchester hospital could change the way cancer is treated

Bhubaneswar, 27th September 2026: A National Expert Deliberation titled “Advancing Bharat’s Indigenous TB Vaccine” convened leading minds across research, healthcare, industry and tuberculosis domain expertise to chart the future course for KochVac. KochVac is an indigenous vaccine candidate being developed through a strategic collaborative framework between IIT Bhubaneswar, the Institute of Life Sciences (ILS) in […]

The September 3 recall involves more than 13,000 bottles.

Great Dane Lilly, aged four, was diagnosed with Osteosarcoma this month despite having no symptoms.

Can a diabetic foot ulcer cause a bone infection? An expert explains the warning signs, diagnosis, treatment and when surgery may be needed.

A single dose of an experimental CRISPR therapy cut LDL cholesterol and triglycerides by about half in patients with difficult-to-treat lipid disorders. The reductions were still present one year later, with the highest dose lowering LDL by 52.5% and triglycerides by 47.8%.

The FDA approved Onswik, a once-weekly insulin for type 2 diabetes, but not for type 1. What the trials showed and the side effects to know.

A range of treatment options are available and can be tailored to how the tremor affects your day-to-day life.

For six years, Alexis Sestito's daughter had the happiest childhood. Then the symptoms began and her mom fought for answers.

Lior ground cinnamon sold in six states since November is recalled over elevated lead. Check for lot GAP11304; young children face the most risk.

Bhubaneswar, 27th September 2026: A National Expert Deliberation titled “Advancing Bharat’s Indigenous TB Vaccine” convened leading minds across research, healthcare, industry and tuberculosis domain expertise to chart the future course for KochVac. KochVac is an indigenous vaccine candidate being developed through a strategic collaborative framework between IIT Bhubaneswar, the Institute of Life Sciences (ILS) in […]

A single dose of an experimental CRISPR therapy cut LDL cholesterol and triglycerides by about half in patients with difficult-to-treat lipid disorders. The reductions were still present one year later, with the highest dose lowering LDL by 52.5% and triglycerides by 47.8%.